In the week of November 9, 2026, 5 holders filed a new Schedule 13D and 71 a new Schedule 13G reporting 5% or more of a company. The largest stake reported that week is LAU Michael Kwok Yan's 98.9% of Energys Group Ltd (Schedule 13D, November 9, 2026).
New 13D5
New 13G71
Stated intents0
The week of 2026-11-09, 5 holders filed a new Schedule 13D and 71 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-11-09 | Energys Group Ltd | LAU Michael Kwok Yan | 98.9% | SCHEDULE 13D |
| 2026-11-09 | Gamehaus Holdings Inc. | Xie Feng | 31.5% | SCHEDULE 13D |
| 2026-11-09 | Highway Holdings Ltd | Lazar David E. | 16.7% | SCHEDULE 13D |
| 2026-11-09 | Aspen Neuroscience, Inc. | ARCH Venture Fund X, L.P. | 12.9% | SCHEDULE 13D |
| 2026-11-09 | GameSquare Holdings, Inc. | Credenza, Inc. | 5.4% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-11-09 | Youlife Group Inc. | L1 Capital Global Opportunities Master Fund, Ltd. | 9.99% | SCHEDULE 13G |
| 2026-11-09 | Blueport Acquisition Ltd | W. R. Berkley Corporation | 9.8% | SCHEDULE 13G |
| 2026-11-09 | NMP Acquisition Corp. | W. R. Berkley Corporation | 9.8% | SCHEDULE 13G |
| 2026-11-09 | Starry Sea Acquisition Corp | W. R. Berkley Corporation | 9.8% | SCHEDULE 13G |
| 2026-11-09 | BHAV Acquisition Corp II | MMCAP International Inc. SPC | 9.7% | SCHEDULE 13G |
| 2026-11-09 | Graf Global Corp. | W. R. Berkley Corporation | 9.1% | SCHEDULE 13G |
| 2026-11-09 | Londian Wason New Energy Tech Inc. | Mirae Asset Global Investments Co., Ltd. | 9% | SCHEDULE 13G |
| 2026-11-09 | Alpex Acquisition Corporation | W. R. Berkley Corporation | 9% | SCHEDULE 13G |
| 2026-11-09 | Shreya Acquisition Group | W. R. Berkley Corporation | 8.9% | SCHEDULE 13G |
| 2026-11-09 | Launch Two Acquisition Corp. | W. R. Berkley Corporation | 8.7% | SCHEDULE 13G |
| 2026-11-09 | Calamos Aksia Private Equity & Alternatives Fund | Calamos Aksia Private Equity and Alternatives Fund (Offshore), Ltd. | 8.7% | SCHEDULE 13G |
| 2026-11-09 | Neighborhood Intelligence, Inc. | Crossingbridge Advisors, LLC | 8.6% | SCHEDULE 13G |
| 2026-11-09 | Sizzle Acquisition Corp. II | W. R. Berkley Corporation | 8.4% | SCHEDULE 13G |
| 2026-11-09 | Braveheart Bio, Inc. | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 8.2% | SCHEDULE 13G |
| 2026-11-09 | Drilling Tools International Corp | Private Management Group Inc | 8.2% | SCHEDULE 13G |
| 2026-11-09 | Rockefeller Capital Management L.P. | SouthState Bank Corp | 8.1% | SCHEDULE 13G |
| 2026-11-09 | Aperture AC | W. R. Berkley Corporation | 8% | SCHEDULE 13G |
| 2026-11-09 | Texas Ventures Acquisition III Corp | W. R. Berkley Corporation | 8% | SCHEDULE 13G |
| 2026-11-09 | Vanguard Scottsdale Funds | NEOS Investment Management LLC | 7.91% | SCHEDULE 13G |
| 2026-11-09 | Newbury Street II Acquisition Corp | The K2 Principal Fund, L.P. | 7.74% | SCHEDULE 13G |
| 2026-11-09 | Pacific Biosciences Of California, Inc. | The Goldman Sachs Group, Inc. | 7.6% | SCHEDULE 13G |
| 2026-11-09 | Newbridge Acquisition Ltd | Hudson Bay Capital Management LP | 7.37% | SCHEDULE 13G |
| 2026-11-09 | Mercator Acquisition Corp. | The Goldman Sachs Group, Inc. | 7.3% | SCHEDULE 13G |
| 2026-11-09 | K2 Capital Acquisition Corp | W. R. Berkley Corporation | 7.3% | SCHEDULE 13G |
| 2026-11-09 | Ocean Capital Acquisition Corporation | W. R. Berkley Corporation | 7.2% | SCHEDULE 13G |
| 2026-11-09 | Burtech Acquisition Corp II | W. R. Berkley Corporation | 7.1% | SCHEDULE 13G |
| 2026-11-09 | Golar Lng Ltd | Luxor Capital Group, LP | 7% | SCHEDULE 13G |
| 2026-11-09 | Aeon Acquisition I Corp. | W. R. Berkley Corporation | 6.8% | SCHEDULE 13G |
| 2026-11-09 | Bellring Brands, Inc. | The Goldman Sachs Group, Inc. | 6.7% | SCHEDULE 13G |
| 2026-11-09 | Clear Channel Outdoor Holdings, Inc. | The Goldman Sachs Group, Inc. | 6.7% | SCHEDULE 13G |
| 2026-11-09 | Cantor Equity Partners I, Inc. | The Goldman Sachs Group, Inc. | 6.6% | SCHEDULE 13G |
| 2026-11-09 | JAB Acquisition Corp I | W. R. Berkley Corporation | 6.6% | SCHEDULE 13G |
| 2026-11-09 | AA Mission Acquisition Corp. II | W. R. Berkley Corporation | 6.6% | SCHEDULE 13G |
| 2026-11-09 | Alpex Acquisition Corporation | The Goldman Sachs Group, Inc. | 6.5% | SCHEDULE 13G |
| 2026-11-09 | Axt Inc | Jane Street Group, LLC | 6.5% | SCHEDULE 13G |
| 2026-11-09 | Jackson Acquisition Company Ii | W. R. Berkley Corporation | 6.5% | SCHEDULE 13G |
| 2026-11-09 | Thayer Ventures Acquisition Corporation Ii | W. R. Berkley Corporation | 6.5% | SCHEDULE 13G |
| 2026-11-09 | ITG, Inc. | W. H. Reaves & Co., Inc. | 6.49% | SCHEDULE 13G |
| 2026-11-09 | Archimedes Tech Spac Partners Ii Co. | The Goldman Sachs Group, Inc. | 6.4% | SCHEDULE 13G |
| 2026-11-09 | Black Spade Acquisition Iii Co | W. R. Berkley Corporation | 6.4% | SCHEDULE 13G |
| 2026-11-09 | Spacsphere Acquisition Corp. | W. R. Berkley Corporation | 6.4% | SCHEDULE 13G |
| 2026-11-09 | Lionheart Holdings | W. R. Berkley Corporation | 6.3% | SCHEDULE 13G |
| 2026-11-09 | GP-Act III Acquisition Corp. | W. R. Berkley Corporation | 6.3% | SCHEDULE 13G |
| 2026-11-09 | Aeon Acquisition I Corp. | The Goldman Sachs Group, Inc. | 6.2% | SCHEDULE 13G |
| 2026-11-09 | AerSale Corp | Private Management Group Inc | 6.2% | SCHEDULE 13G |
| 2026-11-09 | Plutonian Acquisition Corp II | W. R. Berkley Corporation | 6.2% | SCHEDULE 13G |
| 2026-11-09 | Soulpower Acquisition Corporation | W. R. Berkley Corporation | 6.1% | SCHEDULE 13G |
| 2026-11-09 | Exelixis, Inc. | Farallon Capital Management, L.L.C. | 6% | SCHEDULE 13G |
| 2026-11-09 | Oxford Industries, Inc | The Goldman Sachs Group, Inc. | 5.9% | SCHEDULE 13G |
| 2026-11-09 | Tandem Diabetes Care, Inc. | The Goldman Sachs Group, Inc. | 5.9% | SCHEDULE 13G |
| 2026-11-09 | New Providence Acquisition Corp. III | W. R. Berkley Corporation | 5.9% | SCHEDULE 13G |
| 2026-11-09 | Silver Pegasus Acquisition Corp. | W. R. Berkley Corporation | 5.9% | SCHEDULE 13G |
| 2026-11-09 | Sionna Therapeutics, Inc. | The Goldman Sachs Group, Inc. | 5.8% | SCHEDULE 13G |
| 2026-11-09 | Aspen Neuroscience, Inc. | Frazier Life Sciences X, L.P. | 5.8% | SCHEDULE 13G |
| 2026-11-09 | Iambic Therapeutics, Inc. | Qatar Investment Authority | 5.8% | SCHEDULE 13G |
| 2026-11-09 | Flag Ship Acquisition Corporation | W. R. Berkley Corporation | 5.7% | SCHEDULE 13G |
| 2026-11-09 | Tower Semiconductor Ltd | Clal Insurance Enterprises Holdings Ltd | 5.6% | SCHEDULE 13G |
| 2026-11-09 | Jones Ventures INTL Acquisition1 Corp | Hudson Bay Capital Management LP | 5.49% | SCHEDULE 13G |
| 2026-11-09 | Range Capital Acquisition Corp | The Goldman Sachs Group, Inc. | 5.4% | SCHEDULE 13G |
| 2026-11-09 | OceanLight Acquisition Corporation | W. R. Berkley Corporation | 5.4% | SCHEDULE 13G |
| 2026-11-09 | Westin Acquisition Corp. | W. R. Berkley Corporation | 5.4% | SCHEDULE 13G |
| 2026-11-09 | Carter'S, Inc. | The Goldman Sachs Group, Inc. | 5.2% | SCHEDULE 13G |
| 2026-11-09 | Qfin Holdings, Inc. | The Goldman Sachs Group, Inc. | 5.2% | SCHEDULE 13G |
| 2026-11-09 | Immunocore Holdings plc | Point72 Asset Management, L.P. | 5.2% | SCHEDULE 13G |
| 2026-11-09 | Harvard Ave Acquisition Corporation | W. R. Berkley Corporation | 5.2% | SCHEDULE 13G |
| 2026-11-09 | Sutro Biopharma, Inc. | Coastlands Capital LP | 5.14% | SCHEDULE 13G |
| 2026-11-09 | Hyperliquid Strategies Inc | The Goldman Sachs Group, Inc. | 5.1% | SCHEDULE 13G |
| 2026-11-09 | BrightSpire Capital, Inc. | Private Management Group Inc | 5.1% | SCHEDULE 13G |
| 2026-11-09 | EVgo Inc. | CIBC Private Wealth Group LLC | 5.1% | SCHEDULE 13G |
| 2026-11-09 | Sanara Medtech Inc. | The Goldman Sachs Group, Inc. | 5% | SCHEDULE 13G |
| 2026-11-09 | Greenlight Capital Re, Ltd. | Private Management Group Inc | 5% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Download this data (CSV)76 rows, with sources. Free with an account.
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.